Supriya Lifescience Ltd Share Price Today - Supriya Lifescience Ltd Stock Price Live NSE/BSE

Supriya Lifescience Ltd

NSE: SUPRIYA BSE: 543434

₹561.90

(-4.37%)

Thu, 02 Apr 2026, 05:58 pm

MTF 5xInvest in Supriya Lifescience Ltd with 5x Leverage Buy with MTF

Market Cap45.48B

PE Ratio24.41

Dividend0.17

Health Technology

Pharmaceuticals: Major

24.5K

Supriya Lifescience Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
4850.30
Net Profit
187.96
P/B
5.92
Sector P/E
39.23
P/E
31.42
EV/EBITDA
21.53
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
9.71
ROCE (Industry)
13
RONW (Industry)
12.31
ROE
20.74
ROCE
27.43
Debt/Equity
0.01
EPS (TTM)
23.06
Dividend Yield
0.17
Book Value
134.41
Interest Cover
138.28

Analysis

No Result Found

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	68.30	68.30	68.30	68.30	68.30
FII	5.20	5.46	6.78	7.19	6.52
DII	5.01	5.22	4.86	4.26	4.92
Public	21.50	21.02	20.06	20.26	20.26
Government	0	0	0	0	0

Technical Analysis

RSI

50.97

MACD

-17.26

50 DMA

645.12

200 DMA

697.75

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	792.47	688.97	625.43	585.47	521.93	481.97	378.47
Fibonacci	688.97	649.43	625.00	585.47	545.93	521.50	481.97
Camarilla	590.36	580.88	571.39	585.47	552.41	542.92	533.44

Pivots Level: Classic

+207

792.47

+103.50

688.97

+39.97

625.43

585.47

Pivot Point

LTP: 612.20

-63.53

521.93

-103.50

481.97

-207

378.47

Moving Average

SMAEMA

Period

Value

10-EMA
588.87
20-EMA
598.54
30-EMA
612.61
50-EMA
636.95
100-EMA
669.23
200-EMA
680.48

Announcement Date	Purpose	Action	Ex Date
09 Feb 2026	board-meetings	Quarterly Results
02 Sept 2025	agm
05 Aug 2025	dividend	Final Dividend - Rs. - 1	05 Sept 2025
04 Aug 2025	dividend	Dividend - Re 1 Per Share	05 Sept 2025
27 May 2025	dividend	₹1.00 Dividend /Share	05 Sept 2025
13 Sept 2024	agm
20 Aug 2024	dividend	Annual General Meeting/Dividend - Rs 0.80 Per Share	21 Sept 2024
28 May 2024	dividend	₹0.80 Dividend /Share	21 Sept 2024
04 Sept 2023	agm
15 Aug 2023	dividend	Annual General Meeting/Dividend - Re 0.60 Per Share	16 Sept 2023

Supriya Lifescience Ltd

Lupin Ltd

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

Supriya Lifescience Ltd About

Supriya Lifesciences is primarily engaged in manufacturing of Bulk Drugs and Pharmaceutical Chemicals.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2008

Headquarters

CEO

Satish Waman Wagh

Employees

Contact

Website

http://www.supriyalifescience.com

cs@supriyalifescience.com

Phone

91-22-40332727

Location

207/208 Udyog Bhavan, Sonawala Road Goregaon (East), Mumbai, Maharashtra, 400063

Year	History
2018	CEP (Certificate of Sustainability) was granted for Brompheniramine Maleate, Mepyramine Maleate and Ketamine Hydrochloride.
2020	Third time USFDA approval was granted.
2021	CEP (Certificate of Suitability) was granted for Pentoxifylline, Esketamine Hydrochloride and Salbutamol Sulphate. NMPA approval was granted. Health Canada approval was granted.
2022	Supriya Lifescience Limited signed a captive solar project agreement with Enrich Energy Pvt. Ltd.
2024	Supriya Lifescience Ltd inaugurated a state-of-the-art Module E production block at Lote Parshuram, Maharashtra. Supriya Lifescience inaugurated a Rs 125 crore API production block at Lote Parshuram site.

Client Name	Order Side	QTY	Avg Price	Date
GRAVITON RESEARCH CAPITAL LLP	Sell	585068	785.02	22 Nov 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	585068	784.79	22 Nov 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	658285	488.59	12 Aug 2024
GRAVITON RESEARCH CAPITAL LLP	Sell	658285	488.61	12 Aug 2024
GRAVITON RESEARCH CAPITAL LLP	Sell	627793	342.32	08 Feb 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	627793	342.21	08 Feb 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	456665	312.26	26 Dec 2023
GRAVITON RESEARCH CAPITAL LLP	Sell	456665	312.4	26 Dec 2023
GRAVITON RESEARCH CAPITAL LLP	Sell	403147	248.48	12 May 2023
GRAVITON RESEARCH CAPITAL LLP	Buy	403147	248.38	12 May 2023

Supriya Lifescience Ltd News

Supriya Lifescience Independent Directors Complete Tenure

Supriya Lifescience announces completion of five-year tenure for two independent directors on March 24, 2026, with board committees reconstituted accordingly.

24 Mar 2026

companies

Supriya Lifescience Seeks Shareholder Approval for Directors

Supriya Lifescience Limited has issued a postal ballot notice seeking shareholder approval for the appointment of two new independent directors and re-appointment of one existing director through remote e-voting from March 11 to April 10, 2026.

10 Mar 2026

stocks

Supriya Lifescience Q3 FY26 Results Show 11% Growth

Supriya Lifescience reported Q3 FY26 revenue of INR206 crores with 11% YoY growth, maintaining strong EBITDA margins at 34.9% and PAT margins at 24.1%.

17 Feb 2026

co actions results

Supriya Lifescience Q3 FY26 Results Show Growth

Supriya Lifescience reports 11% YoY revenue growth to INR 2,064 Mn in Q3 FY26, with EBITDA up 9% to INR 720.8 Mn and PAT rising 6% to INR 496.8 Mn despite margin compression.

09 Feb 2026

co actions results

Supriya Lifescience Reports 20% Revenue Growth in Q2 FY26, Back on Track After Q1 Disruption

Supriya Lifescience achieved INR 200 crores revenue in Q2 FY26, marking 20% year-on-year and 38% sequential growth, with EBITDA at INR 73 crores and 36% margin. The company maintains its 20% annual revenue growth guidance and INR 1,000 crore revenue target by FY27, supported by new product launches, backward integration at 79%, and upcoming Ambernath facility commercialization from Q4 FY26.

18 Nov 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800